Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

JUBILANT GENERICS

  • FDA Approval
  • March 14, 2025, 08:36 UTC
  • 66
  • 0 comments

FDA approve TELMISARTAN

Comment Full text

JANSSEN PHARMS

  • FDA Approval
  • March 14, 2025, 08:36 UTC
  • 71
  • 0 comments

FDA approve TOPIRAMATE

Comment Full text

ALNYLAM PHARMS INC

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 84
  • 0 comments

FDA approve VUTRISIRAN SODIUM

Comment Full text

SUN PHARM

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 80
  • 0 comments

FDA approve BICALUTAMIDE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 67
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

BAMF

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 67
  • 0 comments

FDA approve FLUDEOXYGLUCOSE F-18

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 65
  • 0 comments

FDA approve TRIMETHOPRIM

Comment Full text

SANDOZ

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 75
  • 0 comments

FDA approve NELARABINE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 69
  • 0 comments

FDA approve EPHEDRINE SULFATE

Comment Full text

KARYOPHARM THERAPS

  • FDA Approval
  • March 12, 2025, 15:23 UTC
  • 78
  • 0 comments

FDA approve SELINEXOR

Comment Full text
  • Previous
  • 222
  • 223
  • 224
  • 225
  • 226
  • Next

Search

News categories

  • Technical Exchange News(11390)
  • Event(2906)
  • SEC News(207375)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(135235)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin